Raymond James & Associates grew its position in shares of The Chemours Company (NYSE:CC – Get Rating) by 1.3% in the 3rd quarter, HoldingsChannel reports. The firm owned 102,638 shares of the specialty chemicals company’s stock after acquiring an additional 1,313 shares during the quarter. Raymond James & Associates’ holdings in Chemours were worth $2,530,000 at the end of the most recent reporting period.
Several other hedge funds have also recently added to or reduced their stakes in the company. CNB Bank purchased a new position in shares of Chemours during the 2nd quarter worth approximately $25,000. Asset Management One Co. Ltd. bought a new position in shares of Chemours during the 2nd quarter valued at $25,000. Trust Co. of Vermont purchased a new position in Chemours during the second quarter valued at $35,000. Ellevest Inc. lifted its position in Chemours by 34,325.0% during the second quarter. Ellevest Inc. now owns 1,377 shares of the specialty chemicals company’s stock valued at $44,000 after purchasing an additional 1,373 shares in the last quarter. Finally, GPS Wealth Strategies Group LLC lifted its position in Chemours by 82.9% during the second quarter. GPS Wealth Strategies Group LLC now owns 1,655 shares of the specialty chemicals company’s stock valued at $53,000 after purchasing an additional 750 shares in the last quarter. Institutional investors own 71.89% of the company’s stock.
Analyst Ratings Changes
Several equities analysts recently weighed in on CC shares. Argus downgraded Chemours from a “buy” rating to a “hold” rating in a research report on Wednesday, October 5th. The Goldman Sachs Group began coverage on Chemours in a report on Thursday, October 13th. They set a “neutral” rating and a $30.00 price target on the stock. Citigroup raised their price target on Chemours from $30.00 to $33.00 and gave the company a “neutral” rating in a report on Thursday, December 15th. StockNews.com raised Chemours from a “hold” rating to a “buy” rating in a report on Saturday, January 14th. Finally, Credit Suisse Group began coverage on Chemours in a report on Tuesday, November 1st. They set an “underperform” rating and a $24.00 price target on the stock. One equities research analyst has rated the stock with a sell rating, eight have given a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $32.90.
Chemours Trading Up 3.4 %
Chemours (NYSE:CC – Get Rating) last released its quarterly earnings results on Tuesday, October 25th. The specialty chemicals company reported $1.24 EPS for the quarter, topping the consensus estimate of $1.16 by $0.08. The company had revenue of $1.80 billion during the quarter, compared to analyst estimates of $1.67 billion. Chemours had a return on equity of 73.45% and a net margin of 12.91%. The firm’s revenue was up 7.1% on a year-over-year basis. During the same quarter last year, the business posted $1.27 earnings per share. Equities research analysts predict that The Chemours Company will post 4.74 EPS for the current fiscal year.
Chemours Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Thursday, December 15th. Investors of record on Tuesday, November 15th were given a $0.25 dividend. The ex-dividend date was Monday, November 14th. This represents a $1.00 annualized dividend and a yield of 2.97%. Chemours’s dividend payout ratio is currently 17.83%.
The Chemours Co is a holding company, which engages in the provision of performance chemicals. The firm delivers solutions, which include a range of industrial and chemical products for markets including coatings, plastics, refrigeration and air conditioning, transportation, semiconductor and consumer electronics, and general industrial.
- Get a free copy of the StockNews.com research report on Chemours (CC)
- MarketBeat Week in Review – 1/16 – 1/20
- Does Old Dominion Show That Trucking Is Hitting The Brakes?
- Nordstrom Puts Fear Of Markdowns Into Retail Sector
- Exxon Mobil Stock: Within Striking Distance Of Buy Point
- High-Dividend-Yielding BHP Sees China Driving ’23 Growth
Receive News & Ratings for Chemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemours and related companies with MarketBeat.com's FREE daily email newsletter.